Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 916Lung Neoplasms 621Small Cell Lung Carcinoma 170Colorectal Neoplasms 133Melanoma 109Breast Neoplasms 107Neoplasms 98Ovarian Neoplasms 94Neoplasm Metastasis 90Pancreatic Neoplasms 76Squamous Cell Carcinoma of Head and Neck 70Stomach Neoplasms 60Carcinoma, Renal Cell 58Head and Neck Neoplasms 55Esophageal Neoplasms 51Endometrial Neoplasms 51Triple Negative Breast Neoplasms 50Prostatic Neoplasms 47Uterine Cervical Neoplasms 44Colonic Neoplasms 42Urinary Bladder Neoplasms 41Mesothelioma 40Carcinoma, Hepatocellular 38Mesothelioma, Malignant 37Brain Neoplasms 34Sarcoma 29Carcinoma, Transitional Cell 29Adenocarcinoma of Lung 28Lung Diseases 26Disease 26

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis × Thoracic × 90 days × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡